Biomebank
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- Holding
- Established
- 2018-12-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.biomebank.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
1
TGA:1
Drug Approvals
Faecal microbiota transplant - BiomeBank (399066)
- Product Name
- Faecal microbiota, frozen - L - BIOMICTRA
- Approval Date
- Nov 9, 2022
TGA
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)No trials found
News
Fecal Microbiota Transplantation Shows Safety and Tolerability in Six-Month Parkinson's Disease Pilot Study
A pilot study of 12 Parkinson's disease patients demonstrated that six-month fecal microbiota transplantation (FMT) therapy is safe and well-tolerated, with 92% completing the full treatment course.